Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Identification of E2F-1/Cyclin A antagonists.

S K Sharma1, T M Ramsey, Y N Chen

  • 1Oncology Department, Novartis Institute for Biomedical Research, Summit, NJ 07901, USA. sushil.sharma@pharma.novartis.com

Bioorganic & Medicinal Chemistry Letters
|September 11, 2001
PubMed
Summary

Researchers developed a novel spirolactam scaffold to create compounds targeting E2F-1/Cyclin A. This work identified potential antagonists for this important biological target.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

First Measurement of a Weak r-Process Reaction on a Radioactive Nucleus.

Physical review letters·2025
Same author

A novel needle-free method of lidocaine administration during standing castration of Holstein bulls.

JDS communications·2024
Same author

Determination of milk concentrations and pharmacokinetics of salicylic acid following acetylsalicylic acid (aspirin) administration in postpartum dairy cows.

Journal of dairy science·2022
Same author

The effects of bolt length on penetration hole characteristics, brain damage and specified-risk material dispersal in finished cattle stunned with a penetrating captive bolt stunner.

Meat science·2019
Same author

Food insecurity and mental illness: disproportionate impacts in the context of perceived stress and social isolation.

Public health·2016
Same author

Investigation of individual and group variability in estrous cycle characteristics in female Asian elephants (Elephas maximus) at the Oregon Zoo.

Theriogenology·2012

Area of Science:

  • Medicinal Chemistry
  • Organic Synthesis
  • Molecular Biology

Background:

  • The E2F-1/Cyclin A complex plays a crucial role in cell cycle regulation.
  • Developing small molecules to inhibit this complex is a key strategy in cancer research.
  • Targeting protein-protein interactions with small molecules presents significant challenges.

Purpose of the Study:

  • To synthesize a novel (S,S)-[Pro-Leu]-spirolactam scaffold.
  • To generate a library of compounds based on the 'ZRXL' motif.
  • To identify antagonists of the E2F-1/Cyclin A complex.

Main Methods:

  • Rational design and synthesis of a spirolactam scaffold.
  • Creation of a biased compound library.
  • Evaluation of compounds using an E2F-1/Cyclin A binding assay.

Related Experiment Videos

  • Structure-activity relationship (SAR) analysis of key amino acid residues.

    • Main Results:

    • A simple and effective synthesis of the (S,S)-[Pro-Leu]-spirolactam scaffold was achieved.
    • A library of compounds mimicking the 'ZRXL' motif was synthesized.
    • Moderately active E2F-1/Cyclin A antagonists were identified.
    • The importance of specific amino acid residues (Phe, Leu, Lys, Arg) in the motif was elucidated.

    Conclusions:

    • The developed spirolactam scaffold is a promising starting point for developing E2F-1/Cyclin A antagonists.
    • The identified compounds show potential for further optimization.
    • This study provides valuable insights into the SAR of E2F-1/Cyclin A inhibitors.